IP Verse

Oral Products With Reduced Irritation - EP4072330

The patent EP4072330 was granted to Nicoventures on Dec 11, 2024. The application was originally filed on Dec 1, 2020 under application number EP20821386A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4072330

NICOVENTURES
Application Number
EP20821386A
Filing Date
Dec 1, 2020
Status
Granted And Under Opposition
Nov 8, 2024
Grant Date
Dec 11, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SWEDISH MATCH NORTH EUROPESep 11, 2025ADMISSIBLE
ALTRIA CLIENT SERVICESSep 10, 2025ADMISSIBLE
JAPAN TOBACCOSep 10, 2025ADMISSIBLE
IMPERIAL TOBACCOSep 9, 2025ADMISSIBLE

Patent Citations (228) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS1086306
DESCRIPTIONUS1376586
DESCRIPTIONUS1437095
DESCRIPTIONUS1757477
DESCRIPTIONUS2004020503
DESCRIPTIONUS2004191322
DESCRIPTIONUS2005115580
DESCRIPTIONUS2005244521
DESCRIPTIONUS2006191548
DESCRIPTIONUS2006236434
DESCRIPTIONUS2007062549
DESCRIPTIONUS2007186941
DESCRIPTIONUS2007186942
DESCRIPTIONUS2008029110
DESCRIPTIONUS2008029116
DESCRIPTIONUS2008173317
DESCRIPTIONUS2008196730
DESCRIPTIONUS2008209586
DESCRIPTIONUS2008305216
DESCRIPTIONUS2009014343
DESCRIPTIONUS2009014450
DESCRIPTIONUS2009065013
DESCRIPTIONUS2009223989
DESCRIPTIONUS2009230003
DESCRIPTIONUS2009250360
DESCRIPTIONUS2009266837
DESCRIPTIONUS2009293889
DESCRIPTIONUS2010084424
DESCRIPTIONUS2010133140
DESCRIPTIONUS2010264157
DESCRIPTIONUS2010282267
DESCRIPTIONUS2010291245
DESCRIPTIONUS2011139164
DESCRIPTIONUS2011168712
DESCRIPTIONUS2011247640
DESCRIPTIONUS2012037175
DESCRIPTIONUS2012055494
DESCRIPTIONUS2012067361
DESCRIPTIONUS2012138073
DESCRIPTIONUS2012138074
DESCRIPTIONUS2013074855
DESCRIPTIONUS2013074856
DESCRIPTIONUS2013152953
DESCRIPTIONUS2013274296
DESCRIPTIONUS2015068545
DESCRIPTIONUS2015101627
DESCRIPTIONUS2015230515
DESCRIPTIONUS2016000140
DESCRIPTIONUS2016073686
DESCRIPTIONUS2016073689
DESCRIPTIONUS2016157515
DESCRIPTIONUS2016192703
DESCRIPTIONUS2017020183
DESCRIPTIONUS2017112183
DESCRIPTIONUS2033909
DESCRIPTIONUS2122421
DESCRIPTIONUS2148147
DESCRIPTIONUS2170107
DESCRIPTIONUS2274649
DESCRIPTIONUS2770239
DESCRIPTIONUS3612065
DESCRIPTIONUS3851653
DESCRIPTIONUS3889689
DESCRIPTIONUS3901248
DESCRIPTIONUS3943940
DESCRIPTIONUS3943945
DESCRIPTIONUS4143666
DESCRIPTIONUS4144895
DESCRIPTIONUS4148325
DESCRIPTIONUS4150677
DESCRIPTIONUS4194514
DESCRIPTIONUS4267847
DESCRIPTIONUS4289147
DESCRIPTIONUS4340073
DESCRIPTIONUS4351346
DESCRIPTIONUS4359059
DESCRIPTIONUS4366823
DESCRIPTIONUS4366824
DESCRIPTIONUS4388933
DESCRIPTIONUS4506682
DESCRIPTIONUS4513756
DESCRIPTIONUS4528993
DESCRIPTIONUS4589428
DESCRIPTIONUS4605016
DESCRIPTIONUS4624269
DESCRIPTIONUS4641667
DESCRIPTIONUS4660577
DESCRIPTIONUS4716911
DESCRIPTIONUS4725440
DESCRIPTIONUS4727889
DESCRIPTIONUS4887618
DESCRIPTIONUS4941484
DESCRIPTIONUS4967771
DESCRIPTIONUS4986286
DESCRIPTIONUS4987907
DESCRIPTIONUS4991599
DESCRIPTIONUS5005593
DESCRIPTIONUS5018540
DESCRIPTIONUS5060669
DESCRIPTIONUS5065775
DESCRIPTIONUS5074319
DESCRIPTIONUS5092352
DESCRIPTIONUS5099862
DESCRIPTIONUS5121757
DESCRIPTIONUS5131414
DESCRIPTIONUS5131415
DESCRIPTIONUS5148819
DESCRIPTIONUS5167244
DESCRIPTIONUS5197494
DESCRIPTIONUS5230354
DESCRIPTIONUS5234008
DESCRIPTIONUS5243999
DESCRIPTIONUS5259403
DESCRIPTIONUS5301694
DESCRIPTIONUS5318050
DESCRIPTIONUS5343879
DESCRIPTIONUS5360022
DESCRIPTIONUS5387416
DESCRIPTIONUS5435325
DESCRIPTIONUS5445169
DESCRIPTIONUS5539093
DESCRIPTIONUS5668295
DESCRIPTIONUS5705624
DESCRIPTIONUS5713376
DESCRIPTIONUS5844119
DESCRIPTIONUS5908032
DESCRIPTIONUS6077524
DESCRIPTIONUS6131584
DESCRIPTIONUS6298859
DESCRIPTIONUS6510855
DESCRIPTIONUS6668839
DESCRIPTIONUS6730832
DESCRIPTIONUS6772767
DESCRIPTIONUS6834654
DESCRIPTIONUS6887307
DESCRIPTIONUS6895974
DESCRIPTIONUS6923981
DESCRIPTIONUS6953040
DESCRIPTIONUS7014039
DESCRIPTIONUS7025066
DESCRIPTIONUS7032601
DESCRIPTIONUS7173170
DESCRIPTIONUS7208659
DESCRIPTIONUS7230160
DESCRIPTIONUS7337782
DESCRIPTIONUS7537110
DESCRIPTIONUS7556047
DESCRIPTIONUS7584843
DESCRIPTIONUS7650892
DESCRIPTIONUS7694686
DESCRIPTIONUS7798153
DESCRIPTIONUS7861728
DESCRIPTIONUS787611
DESCRIPTIONUS8061362
DESCRIPTIONUS8186360
DESCRIPTIONUS8397945
DESCRIPTIONUS8434496
DESCRIPTIONUS8931493
DESCRIPTIONUS8944072
DESCRIPTIONUS8991403
DESCRIPTIONUS9237769
DESCRIPTIONUS9339058
DESCRIPTIONUS9420825
DESCRIPTIONUS9950858
DESCRIPTIONUSD592956S
DESCRIPTIONUSD594154S
DESCRIPTIONUSD625178S
DESCRIPTIONWO2004095959
DESCRIPTIONWO2005041699
DESCRIPTIONWO2005063060
DESCRIPTIONWO2008103935
DESCRIPTIONWO2010132444
DESCRIPTIONWO2018083114
DESCRIPTIONWO9631255
INTERNATIONAL-SEARCH-REPORTSE1750488
INTERNATIONAL-SEARCH-REPORTUS2010300464
INTERNATIONAL-SEARCH-REPORTUS2013074856
INTERNATIONAL-SEARCH-REPORTUS2014261485
INTERNATIONAL-SEARCH-REPORTUS2014271946
INTERNATIONAL-SEARCH-REPORTUS2015068545
INTERNATIONAL-SEARCH-REPORTWO2007053098
INTERNATIONAL-SEARCH-REPORTWO2011117740
INTERNATIONAL-SEARCH-REPORTWO2015067372
INTERNATIONAL-SEARCH-REPORTWO2018197454
OPPOSITIONEP0371584
OPPOSITIONEP3087852
OPPOSITIONGB2230439
OPPOSITIONSE1750488
OPPOSITIONUS2003031710
OPPOSITIONUS2003087937
OPPOSITIONUS2010247586
OPPOSITIONUS2010300464
OPPOSITIONUS2011288132
OPPOSITIONUS2012031415
OPPOSITIONUS2012052021
OPPOSITIONUS2012128734
OPPOSITIONUS2012247492
OPPOSITIONUS2013074856
OPPOSITIONUS2013078307
OPPOSITIONUS2014261485
OPPOSITIONUS2014271946
OPPOSITIONUS2015068545
OPPOSITIONUS2016157515
OPPOSITIONUS2018140591
OPPOSITIONUS8828361
OPPOSITIONWO0035296
OPPOSITIONWO2004070017
OPPOSITIONWO2007053098
OPPOSITIONWO2010104464
OPPOSITIONWO2011117735
OPPOSITIONWO2011117740
OPPOSITIONWO2012134380
OPPOSITIONWO2013043835
OPPOSITIONWO2013103318
OPPOSITIONWO2014151434
OPPOSITIONWO2015035311
OPPOSITIONWO2015067372
OPPOSITIONWO2017093487
OPPOSITIONWO2018197454
OPPOSITIONWO2018233795
OPPOSITIONWO2019110073
OPPOSITIONWO2020187812
OPPOSITIONWO2020244723
OPPOSITIONWO2021053078
OPPOSITIONWO2021086367
OPPOSITIONWO2021099571
OPPOSITIONWO9101132
OPPOSITIONWO9503050

Non-Patent Literature (NPL) Citations (18) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- NESTOR et al., Beitrage Tabakforsch. Int., (20030000), vol. 20, pages 467 - 475-
DESCRIPTION- PERFETTI, Beitrage Tabakforschung Int., (19830000), vol. 12, pages 43 - 54-
DESCRIPTION- SANTHOSH et al., Phytomedicine, (20050000), vol. 12, pages 216 - 220-
DESCRIPTION- STAAF et al., Beitrage Tabakforsch. Int., (20050000), vol. 21, pages 321 - 330-
DESCRIPTION- The EFSA Journal, (20040000), vol. 85, pages 1 - 32-
OPPOSITION- Anonymous, "Eugenol (Clove Oil)", NCBI Bookshelf, NCBI Bookshelf, URL: https://www.ncbi.nlm.nih.gov/books/NBK551727/, XP093314210-
OPPOSITION- Anonymous, "G4 FU:ZN (Apple Mint) Slim All White - Review (Discontinued)", Snubie.com, Snubie.com, URL: https://chadizzy1.blogspot.com/2018/02/g4-fuzn-apple-mint-slim-all-white.html, XP093314200-
OPPOSITION- Anonymous, " POLYOLS FOR Personal & Oral Care Applications", Ingredion, Ingredion, URL: https://www.ingredion.com/content/dam/ingredion/pdf-downloads/Canada-Assets/factsheets/Polyols_PersonalOralCare_FS.pdf, XP093314208-
OPPOSITION- Anonymous, "Use of non-sugar sweeteners - WHO guideline", WHO, WHO, URL: https://iris.who.int/bitstream/handle/10665/367660/9789240073616-eng.pdf?sequence=1, XP093314209-
OPPOSITION- D12 - WebMD, Clove - Uses, Side Effects, and More (no date found in text)-
OPPOSITION- D14 - SnusPort, “G.4 FU:ZN Apple Mint Slim All White” (no date found in text)-
OPPOSITION- France Lyon, 2007, "IARC Monographs on the Evaluation of Carcinogenic Risks to Humans WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines", URL: http://monographs.iarc.fr/ENG/Monographs/vol89/mono89.pdf, (20150210), XP055168551-
OPPOSITION- De Feo Martina, Paladini Antonella, Ferri Claudio, Carducci Augusto, Del Pinto Rita, Varrassi Giustino, Grassi Davide, "Anti-Inflammatory and Anti-Nociceptive Effects of Cocoa: A Review on Future Perspectives in Treatment of Pain", Pain and Therapy, Springer Healthcare, (20200601), vol. 9, no. 1, doi:10.1007/s40122-020-00165-5, ISSN 2193-8237, pages 231 - 240, XP093314211
OPPOSITION- Xuesheng Han, Tory L. Parker, "Anti-inflammatory activity of clove ( Eugenia caryophyllata ) essential oil in human dermal fibroblasts", PHARMACEUTICAL BIOLOGY, SWETS AND ZEITLINGER, LISSE,, NL, NL , (20170101), vol. 55, no. 1, doi:10.1080/13880209.2017.1314513, ISSN 1388-0209, pages 1619 - 1622, XP055756124
OPPOSITION- E. Szél, H. Polyánka, K. Szabó, P. Hartmann, D. Degovics, B. Balázs, I.B. Németh, C. Korponyai, E. Csányi, J. Kaszaki, S. Dikstein, K. Nagy, L. Kemény, G. Erős, "Anti-irritant and anti-inflammatory effects of glycerol and xylitol in sodium lauryl sulphate-induced acute irritation", JEADV , The Journal of the European Academy of Dermatology and Venereology, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, NL , (20151201), vol. 29, no. 12, doi:10.1111/jdv.13225, ISSN 0926-9959, pages 2333 - 2341, XP055511308
OPPOSITION- Robichaud Meagan O, Seidenberg Andrew B, Byron M. Justin, "Tobacco companies introduce ‘tobacco-free’ nicotine pouches", Tobacco control, BMJ Publishing Group LTD, England, England , doi:10.1136/tobaccocontrol-2019-055321, pages e145 - e146, Tobacco control, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239723/pdf/nihms-1061097.pdf, (20210423), XP055798334
OPPOSITION- Kulic, "Analysis of cellulose in stalks and leaves of large leaf tobacco", Journal of Agricultural Sciences, (2011), vol. 56, doi:10.2298/JAS1103207K, XP055480957
OPPOSITION- Taher Yousef A., Samud Awatef M., El-Taher Fathy E., Ben-Hussin Ghazala, Elmezogi Jamal S., Al-Mehdawi Badryia F., Salem Hanan A., "Experimental evaluation of anti-inflammatory, antinociceptive and antipyretic activities of clove oil in mice", The Libyan journal of medicine, CoAction Publishing, Sweden, Sweden , (20150101), vol. 10, no. 1, doi:10.3402/ljm.v10.28685, ISSN 1993-2820, page 28685, XP093314206

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents